1. ALLA AKTIER
  2. NYHETER
  3. MENTICE

Mentice

Nyheter Mentice Nyheter alla bolag
Slipp dessa annonser och få en massa andra godsaker med vårt premiumabonnemang.

Mentice receives an order of USD 652,000 for VIST® simulation solutions from Medtronic

MAR

Sweden-Gothenburg, February 15, 2023

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Medtronic, Dublin (NYSE: MDT), a global healthcare technology leader, has signed an agreement to acquire Mentice VIST® simulation solutions for 652,000 USD.

For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: goran.malmberg@mentice.com
US Mobile. +1 (312) 860 5610
Sweden Mobile +46 (0) 703 09 22 22

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB

This information is information that Mentice is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-02-15 08:30 CET.

Attachments
Mentice receives an order of USD 652,000 for VIST® simulation solutions from Medtronic

Datum 2023-02-15, kl 08:30
Källa MFN
Bifogade filer
Mentice receives an order of USD 652,000 for VIST® simulation solutions from Medtronic